BioFocus, a lprovider of integrated gene-to-clinical candidate drug discovery services and eMolecules Inc, the creators of the open-access chemical structure search engine, today announced that they have signed a compound management service agreement.
Under the agreement eMolecules has selected Compound Focus Inc, the BioFocus compound management operation located in South San Francisco, as its preferred partner for client compound order aggregation services.
Clients that order compounds from multiple vendors through the eMolecules platform will have the option to ship their compounds directly from the vendor to the Compound Focus facility where both liquid and solid samples will be reformatted into preferred storage containers, passed through analytical quality control and shipped to an agreed client destination.
“We are pleased to be the chosen partner of eMolecules as they look to bring the business of compound procurement into the 21st century” said Scott Snyder, Senior Director Compound Focus Inc. “Compound Focus’ full suite of compound management capabilities is well suited to support the broad spectrum of our client requirements,” said Klaus Gubernator, CEO of eMolecules.
